Affiliated with Université Laval & CERVO Research Centre

Publications

Export 13 results:
Author Title Type [ Year(Asc)]
Filters: Author is Castonguay, Annie  [Clear All Filters]
2019
Castonguay A, Lorenzo L-E, Wiseman PW, Ribeiro-da-Silva A, De Koninck Y, Godin AG.  2019.  Revealing Abnormal Oligomerization of Proteins in Single Cells. 116(3, Supplement 1):426a.
2017
Gagnon M, Bergeron MJ, Perez-Sanchez J, Plasencia-Fernández I, Lorenzo L-E, Godin AG, Castonguay A, Bonin RP, De Koninck Y.  2017.  Reply to The small molecule CLP257 does not modify activity of the K-Cl co-transporter KCC2 but does potentiate GABA receptor activity.. Nat Med. 23(12):1396-1398.
2016
Miraucourt LS, Tsui J, Gobert D, Desjardins J-F, Schohl A, Sild M, Spratt P, Castonguay A, De Koninck Y, Marsh-Armstrong N et al..  2016.  Endocannabinoid signaling enhances visual responses through modulation of intracellular chloride levels in retinal ganglion cells.. Elife. 5
Taylor AMW, Castonguay A, Ghogha A, Vayssiere P, Pradhan AAA, Xue L, Mehrabani S, Wu J, Levitt P, Olmstead MC et al..  2016.  Neuroimmune Regulation of GABAergic Neurons Within the Ventral Tegmental Area During Withdrawal from Chronic Morphine.. Neuropsychopharmacology. 41(4):949-59.
2015
Ford A, Castonguay A, Cottet M, Little JW, Chen Z, Symons-Liguori AM, Doyle T, Egan TM, Vanderah TW, De Koninck Y et al..  2015.  Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain.. J Neurosci. 35(15):6057-67.
Taylor AMW, Castonguay A, Taylor AJ, Murphy NP, Ghogha A, Cook C, Xue L, Olmstead MC, De Koninck Y, Evans CJ et al..  2015.  Microglia disrupt mesolimbic reward circuitry in chronic pain.. J Neurosci. 35(22):8442-50.
2014
Thériault G, Cottet M, Castonguay A, McCarthy N, De Koninck Y.  2014.  Extended two-photon microscopy in live samples with Bessel beams: steadier focus, faster volume scans, and simpler stereoscopic imaging.. Front Cell Neurosci. 8:139.
Bergeron MJ, Castonguay A, De Koninck Y.  2014.  [KCC2: a new therapeutical target for the treatment of neurological diseases].. Med Sci (Paris). 30(5):514-7.
2013
Gagnon M, Bergeron MJ, Lavertu G, Castonguay A, Tripathy S, Bonin RP, Perez-Sanchez J, Boudreau D, Wang B, Dumas L et al..  2013.  Chloride extrusion enhancers as novel therapeutics for neurological diseases.. Nat Med. 19(11):1524-8.
Ferrini F, Trang T, Mattioli T-AM, Laffray S, Del'Guidice T, Lorenzo L-E, Castonguay A, Doyon N, Zhang W, Godin AG et al..  2013.  Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl⁻ homeostasis.. Nat Neurosci. 16(2):183-92.
2012
Caillier B, Pilote S, Castonguay A, Patoine D, Ménard-Desrosiers V, Vigneault P, Hreiche R, Turgeon J, Daleau P, De Koninck Y et al..  2012.  QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile.. Fundam Clin Pharmacol. 26(5):599-608.
2011
Doyon N, Prescott SA, Castonguay A, Godin AG, Kröger H, De Koninck Y.  2011.  Efficacy of synaptic inhibition depends on multiple, dynamically interacting mechanisms implicated in chloride homeostasis.. PLoS Comput Biol. 7(9):e1002149.